|
The TheraBoost project represents a strategic investment of €689,099.20, supported by the Portuguese National Innovation Agency (ANI). Co-funded under the Innovation and Digital Transition Program (PITD) of COMPETE 2030, TheraBoost is dedicated to the development of a multifunctional biomaterial platform designed to drive innovation across a broad range of industrial applications, with a strong impact on personalised medicine and efficient formulation of next-generation cell and gene therapy products.
|
|
